Zai Lab LtdZLAB

Zai Lab Ltd Revenue Disclosure

10-KFiled Feb 26, 20261 min read
Revenues
Product Revenue, Net
The Company’s product revenue is derived from the sales of its commercial products in Greater China. The table below presents the Company’s gross and net product revenue ($ in thousands):
Year Ended December 31,
202520242023
Product revenue - gross496,232 423,855 298,911 
Less: Rebates and sales returns(39,050)(26,241)(32,192)
Product revenue - net457,182 397,614 266,719 
Sales rebates are offered to distributors in mainland China, and the amounts are recorded as a reduction of product revenue. Estimated rebates are determined based on contracted rates, sales volumes, and level of distributor inventories.
The following table presents the Company’s net revenue by commercial program ($ in thousands):
Year Ended December 31,
202520242023
ZEJULA189,042 187,082 168,843 
VYVGART / VYVGART Hytrulo
94,198 93,639 10,011 
NUZYRA60,836 43,199 21,656 
OPTUNE48,325 40,475 46,969 
QINLOCK35,614 28,826 19,240 
XACDURO22,912 3,305 — 
AUGTYRO5,538 1,088 — 
Other (i)717 — — 
Product revenue - net457,182 397,614 266,719 
(i)Other includes product candidates sold in patient programs prior to commercialization.
Collaboration Revenue
Collaboration revenue was $3.0 million, $1.4 million, and nil in 2025, 2024, and 2023, respectively, and related to promotional activities in mainland China.

Historical Timeline

Fiscal YearFiled
2025Feb 26, 2026Showing above
2024Feb 27, 2025

About Revenue Disclosures

Revenue disclosures under ASC 606 explain how a company identifies performance obligations, allocates transaction prices, and determines when revenue is recognized. This section is essential for understanding whether reported revenue reflects genuine economic activity or aggressive accounting choices. Analysts examine the mix of point-in-time versus over-time recognition, which directly affects revenue timing and comparability.

Key signals: rising contract liabilities (deferred revenue) suggest strong future revenue visibility, while declining contract assets may indicate slowing project milestones. Watch for variable consideration estimates — rebates, returns, and performance bonuses that require management judgment. Significant changes in disaggregated revenue by geography or product line can reveal shifting business mix before it appears in headline numbers. Compare revenue growth against contract liability growth to assess sustainability, and scrutinize any changes in the timing of recognition that coincide with earnings pressure.

Other Available Disclosures

Income TaxesEarnings Per SharePP&ELeasesSegmentsDebtCommitmentsStock CompensationNew Standards